當(dāng)前位置：珀金埃爾默醫(yī)學(xué)診斷產(chǎn)品（上海）有限公司>>>>hNMU2 (FM4) CHO-K1 cell line

hNMU2 (FM4) CHO-K1 cell line

返回列表頁

參考價(jià)

面議

具體成交價(jià)以合同協(xié)議為準(zhǔn)

產(chǎn)品型號

品牌

廠商性質(zhì)其他

所在地

在線詢價(jià) 收藏產(chǎn)品查看聯(lián)系電話

聯(lián)系方式：查看聯(lián)系方式

更新時(shí)間：2022-10-15 15:49:13瀏覽次數(shù)：56次

聯(lián)系我時(shí)，請告知來自環(huán)保在線

產(chǎn)品分類 品牌分類

暫無信息

珀金埃爾默醫(yī)學(xué)診斷產(chǎn)品（上海）有限公司

經(jīng)營模式：其他

商鋪產(chǎn)品：677條

所在地區(qū)：

詢價(jià) 給他留言

產(chǎn)品簡介

Stable, recombinant ValiScreen® cell line expressing the Neuromedin U receptor NMU2, human recombinant in CHO-K1 host cells.

詳細(xì)介紹

PerkinElmer’s ValiScreen^® cell lines are provided in two vials of frozen cells, each containing ∽2.5 x 10⁶ cells. Detailed product information as well as recommended cell culture conditions and validation assay date are available for each cell line.

Clonal selection for PerkinElmer’s ValiScreen cell lines is carried out with receptor binding. High and low expressors are then tested and selected for optimal binding and functional response according to the receptor specific transduction pathway.

PerkinElmer’s ValiScreen cell lines require accepted cell line Terms and Conditions prior to order processing. Additional agreement needed for commercial use. Contact us using the Request More Information button above for additional information regarding required documentation.